EMERALD Study will investigate safety and efficacy of engineered macrophage cell therapy in patients with decompensated liver cirrhosis LONDON and EDINBURGH, Scotland, June 27, 2024 /PRNewswire/ — Resolution Therapeutics Limited (“Resolution”), a clinical-stage biopharmaceutical company…